Climb Bio Stock Price on November 8, 2024
| CLYM Stock | 2.10 0.17 7.49% |
If you're considering investing in Climb Stock, it is important to understand the factors that can impact its price. As of today, the current price of Climb Bio stands at 2.10, as last reported on the 30th of December, with the highest price reaching 2.29 and the lowest price hitting 2.04 during the day. Climb Bio secures Sharpe Ratio (or Efficiency) of -0.27, which signifies that the company had a -0.27% return per unit of risk over the last 3 months. Climb Bio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Climb Bio's Standard Deviation of 4.81, mean deviation of 3.65, and Risk Adjusted Performance of (0.21) to double-check the risk estimate we provide.
At this time, Climb Bio's Total Stockholder Equity is very stable compared to the past year. As of the 30th of December 2024, Common Stock Shares Outstanding is likely to grow to about 28.6 M, while Capital Stock is likely to drop 2,565. . Climb Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Climb |
Sharpe Ratio = -0.2716
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLYM |
Estimated Market Risk
| 4.8 actual daily | 42 58% of assets are more volatile |
Expected Return
| -1.3 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.27 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Climb Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Climb Bio by adding Climb Bio to a well-diversified portfolio.
Climb Bio Main Headline on 8th of November 2024
Insider Trading by Williams Douglas E Filed transaction by Climb Bio Executive. Insider Public Trading |
Climb Bio Valuation on November 8, 2024
It is possible to determine the worth of Climb Bio on a given historical date. On November 8, 2024 Climb was worth 3.52 at the beginning of the trading date compared to the closed value of 3.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Climb Bio stock. Still, in general, we apply an absolute valuation method to find Climb Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Climb Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Climb Bio's related companies.
| Open | High | Low | Close | Volume | |
| 3.63 | 3.79 | 3.49 | 3.52 | 362,515 | |
11/08/2024 | 3.52 | 3.80 | 3.52 | 3.79 | 382,857 |
| 3.82 | 4.32 | 3.82 | 4.06 | 307,651 |
| Backtest Climb Bio | | | Climb Bio History | | | Climb Bio Valuation | Previous | Next |
Climb Bio Trading Date Momentum on November 8, 2024
| On November 11 2024 Climb Bio was traded for 4.06 at the closing time. The top price for the day was 4.32 and the lowest listed price was 3.82 . The trading volume for the day was 307.7 K. The trading history from November 11, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 7.12% . The overall trading delta against the current closing price is 20.32% . |
Climb Bio Fundamentals Correlations and Trends
By evaluating Climb Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Climb Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Climb financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Climb Bio Stock history
Climb Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Climb is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Climb Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Climb Bio stock prices may prove useful in developing a viable investing in Climb Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 27.7 M | 28.6 M |
Climb Bio Quarterly Net Working Capital |
|
Climb Bio Stock Technical Analysis
Climb Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Climb Bio Period Price Range
Low | December 30, 2024
| High |
0.00 | 0.00 |
Climb Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Climb Bio December 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Climb Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Climb Bio shares will generate the highest return on investment. By undertsting and applying Climb Bio stock market strength indicators, traders can identify Climb Bio entry and exit signals to maximize returns
Climb Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Climb Bio's price direction in advance. Along with the technical and fundamental analysis of Climb Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Climb to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.21) | |||
| Jensen Alpha | (1.35) | |||
| Total Risk Alpha | (1.48) | |||
| Treynor Ratio | (4.07) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Climb Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. To learn how to invest in Climb Stock, please use our How to Invest in Climb Bio guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Climb Bio. If investors know Climb will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Climb Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Climb Bio is measured differently than its book value, which is the value of Climb that is recorded on the company's balance sheet. Investors also form their own opinion of Climb Bio's value that differs from its market value or its book value, called intrinsic value, which is Climb Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Climb Bio's market value can be influenced by many factors that don't directly affect Climb Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Climb Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Climb Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Climb Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.